Serum iron levels as a new biomarker in chemotherapy with leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan, with or without molecularly-targeted drugs

Serum iron levels have been reported to increase following the administration of various anticancer drugs. An increase in serum iron levels during therapy with leucovorin and fluorouracil plus oxaliplatin (FOLFOX) or leucovorin and fluorouracil plus irinotecan (FOLFIRI) was also observed. The aim of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: OCHIAI, TAKUMI, NISHIMURA, KAZUHIKO, WATANABE, TOMOO, KITAJIMA, MASAYUKI, NAKATANI, AKINORI, INOU, TAKASHI, SHIBATA, HIDEKI, SATO, TSUYOSHI, KISHINE, KENJI, SEO, SHOUGO, OKUBO, SATOSHI, FUTAGAWA, SHUNJI, MASHIKO, SATOMI, NAGAOKA, ISAO
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2013
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3916199/
https://ncbi.nlm.nih.gov/pubmed/24649250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2013.136
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars